M2 Macrophages Promote PDGFRβ+ Pericytes Migration After Spinal Cord Injury in Mice via PDGFB/PDGFRβ Pathway

Ziyu Li1, Meige Zheng1, Shuisheng Yu1

  • 1Department of Orthopaedics, The Second Hospital of Anhui Medical University, Hefei, China.

Insights

Macrophages polarization influences Platelet-Derived Growth Factor Receptor Beta positive (PDGFRβ+) pericyte migration after spinal cord injury (SCI). M2 macrophages secrete PDGFB, promoting pericyte migration via the PDGFB/PDGFRβ pathway, a potential therapeutic target for SCI.

Area of Science:

  • Neuroscience
  • Immunology
  • Regenerative Medicine

Background:

  • Platelet-derived growth factor receptor β positive (PDGFRβ+) pericytes contribute to fibrotic scarring, inhibiting axonal regeneration post-spinal cord injury (SCI).
  • The precise mechanisms driving PDGFRβ+ pericyte migration to the SCI core remain largely unknown.

Purpose of the Study:

  • To investigate the role of macrophage polarization in regulating PDGFRβ+ pericyte migration following SCI.
  • To elucidate the molecular pathways involved in this interaction.

Main Methods:

  • Analysis of macrophage polarization (M1/M2) and PDGFRβ+ pericyte distribution at different time points post-SCI (3, 7, 14 days).
  • Assessment of platelet-derived growth factor B (PDGFB) expression.
  • In vitro experiments using exogenous PDGFB and M2 macrophage conditioned medium to evaluate pericyte migration, with and without the PDGFRβ inhibitor SU16f.

Main Results:

  • Macrophage distribution correlated spatially and temporally with PDGFRβ+ pericytes in the SCI core.
  • M2 macrophage polarization was observed early post-injury (3, 7 dpi), preceding M1 polarization (14 dpi).
  • PDGFB expression increased post-SCI and with M2 polarization. PDGFB and M2 conditioned medium promoted pericyte migration, an effect inhibited by SU16f.

Conclusions:

  • M2 macrophages secrete PDGFB, which promotes PDGFRβ+ pericyte migration by activating the PDGFB/PDGFRβ pathway.
  • Inhibition of the PDGFB/PDGFRβ pathway using SU16f can block this migration.
  • The PDGFB/PDGFRβ pathway represents a promising therapeutic target for mitigating scar formation and promoting axonal regeneration after SCI.

Related Concept Videos